{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:28:58Z","timestamp":1778254138919,"version":"3.51.4"},"reference-count":35,"publisher":"ALUNA","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wiad Lek"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>The aim: To analyze CR among antibacterials of different classes and to overcome some widespread misconceptions regarding CR between different classes of antibiotics. \nMaterials and methods: The narrative review represents an assessment of the most pertinent literary sources published in English language, which dealt with the issues of cross-reactivity between individual antibiotics and different classes of these ones. \nConclusions: With a high probability of type I AR in a patient in the past, it is better to plan the treatment of patients together with an allergist \/ immunologist. If this probability is estimated to be low, the choice of a particular antibiotic may be based to some extent on CR data.<\/jats:p>","DOI":"10.36740\/wlek202207126","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T13:13:55Z","timestamp":1660396435000},"page":"1752-1756","source":"Crossref","is-referenced-by-count":1,"title":["CROSS-REACTIVITY TO ANTIBIOTICS: PROPOSITIONS FOR SELECTING ALTERNATIVES"],"prefix":"10.36740","volume":"75","author":[{"given":"Igor","family":"Bereznyakov","sequence":"first","affiliation":[{"name":"KHARKIV MEDICAL ACADEMY OF POSTGRADUATE EDUCATION, KHARKIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliia","family":"Imanova","sequence":"additional","affiliation":[{"name":"KHARKIV MEDICAL ACADEMY OF POSTGRADUATE EDUCATION, KHARKIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksana","family":"Doroshenko","sequence":"additional","affiliation":[{"name":"KHARKIV MEDICAL ACADEMY OF POSTGRADUATE EDUCATION, KHARKIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryna","family":"Lebedynska","sequence":"additional","affiliation":[{"name":"KHARKIV MEDICAL ACADEMY OF POSTGRADUATE EDUCATION, KHARKIV, UKRAINE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22436","published-online":{"date-parts":[[2022]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Blumenthal K.G., Lu N., Zhang Y. et al. Risk of methicillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. BMJ. 2018; 361: 2400.","DOI":"10.1136\/bmj.k2400"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Zagursky R.J., Pichichero M.E. Cross-reactivity in \u03b2-lactam allergy J. Allergy Clin. Immunol. Pract. 2018; 6:72-81.","DOI":"10.1016\/j.jaip.2017.08.027"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Romano A., Gaeta F., Arribas Poves M.F. et al. Cross-reactivity among beta-lactams. Curr. Allergy Asthma Rep. 2016;16:24.","DOI":"10.1007\/s11882-016-0594-9"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Romano A., Valluzzi R.L., Caruso C. et al. Cross-reactivity and tolerability of cephalosporins in patients with IgE-mediated hypersensitivity to penicillins. J. Allergy Clin. Immunol. Pract. 2018; 6:1662-72.","DOI":"10.1016\/j.jaip.2018.01.020"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Stone C.A.Jr., Trubiano J., Coleman D.T. et al. The challenge of de\u2013 labeling penicillin allergy. Allergy. 2020; 75 (2): 273-288.","DOI":"10.1111\/all.13848"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Pichichero M.E., Zagursky R. Penicillin and cephalosporin allergy. Ann. Allergy Asthma Immunol. 2014; 112:404-12.","DOI":"10.1016\/j.anai.2014.02.005"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7. Kelkar P.S., Li J.T. Cephalosporin allergy. N. Engl. J. Med. 2001; 345:804-9.","DOI":"10.1056\/NEJMra993637"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Pichichero M.E., Casey J.R. Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngol. Head Neck Surg. 2007; 136:340-7.","DOI":"10.1016\/j.otohns.2006.10.007"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann. Allergy Asthma Immunol. 2010; 105:259-73.","DOI":"10.1016\/j.anai.2010.08.002"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Zhao Z., Baldo B.A., Rimmer J. Beta-lactam allergenic determinants: fine structural recognition of a cross-reacting determinant on benzylpenicillin and cephalothin. Clin. Exp. Allergy. 2002; 32:1644-50.","DOI":"10.1046\/j.1365-2222.2002.01492.x"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Baldo B.A., Pham N.H. Beta-lactam antibiotics. In: Baldo BA, Pham NH, editors. Drug allergy: clinical aspects, diagnosis, mechanisms, structure-activity relationships. New York: Springer; 2013, 129p.","DOI":"10.1007\/978-3-030-51740-3_5"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Romano A., Gaeta F., Valluzzi R.L. et al. IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of alternative cephalosporins. J. Allergy Clin. Immunol. 2015; 136:685-691.e3.","DOI":"10.1016\/j.jaci.2015.03.012"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Chaudhry S.B., Veve M.P., Wagner J.L. Cephalosporins: a focus on side chains and \u03b2-lactam cross-reactivity. Pharmacy. 2019; 7:103.","DOI":"10.3390\/pharmacy7030103"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Atanaskovic-Markovic M., Gaeta F., Gavrovic-Jankulovic M. et al. Tolerability of imipenem in children with IgE-mediated hypersensitivity to penicillins. J. Allergy Clin. Immunol. 2009; 124:167-9.","DOI":"10.1016\/j.jaci.2009.02.031"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Gaeta F., Valluzzi R.L., Alonzi C. et al. Tolerability of aztreonam and carbapenems in patients with IgE-mediated hypersensitivity to penicillins. J. Allergy Clin. Immunol. 2015; 135:972-6.","DOI":"10.1016\/j.jaci.2014.10.011"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16. Broyles A.D., Banerji A., Barmettler S. et al. Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs. J. Allergy Clin. Immunol. Pract. 2020; 8 (9S): 16-116.","DOI":"10.1016\/j.jaip.2020.08.002"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Devchand M., Trubiano J.A. Penicillin allergy: a practical approach to assessment and prescribing. Aust. Prescr. 2019; 42:192\u20139.","DOI":"10.18773\/austprescr.2019.065"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Caruso C., Valluzzi R.L., Colantuono S. et al. \u03b2-Lactam allergy and cross-reactivity: a clinician\u2019s guide to selecting an alternative antibiotic. J. Asthma Allergy. 2021; 14: 31\u201346.","DOI":"10.2147\/jaa.s242061"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Do\u00f1a I., Moreno E., P\u00e9rez-S\u00e1nchez N. et al. Update on quinolone allergy. Curr. Allergy Asthma Rep. 2017; 17:56.","DOI":"10.1007\/s11882-017-0743-9"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Blanca-Lopez N., Ariza A., Do\u00f1a I. et al. Hypersensitivity reactions to fluoroquinolones: analysis of the factors involved. Clin. Exp. Allergy. 2013; 43:560\u2013567.","DOI":"10.1111\/cea.12099"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Jones S.C., Budnitz D., Sorbello A. et al. US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions. Pharmacoepidemiol. Drug Saf. 2013; 22:1099\u20131106.","DOI":"10.1002\/pds.3499"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"22. McGee E.U., Samuel E., Boronea B. et al. Quinolone allergy. Pharmacy. 2019; 7: 97.","DOI":"10.3390\/pharmacy7030097"},{"key":"ref22","unstructured":"23. Lobera T., Audicana M.T., Alarcon E. et al. Allergy to quinolones: low cross-reactivity to levofloxacin. J. Investig. Allergol. Clin. Immunol. 2010; 20:607\u2013611."},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"24. Araujo L., Demoly P. Macrolides allergy. Curr. Pharm. Des. 2008; 14:2840- 62.","DOI":"10.2174\/138161208786369812"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Mori F., Pecorari L., Pantano S. et al. Azithromycin anaphylaxis in children. Int. J. Immunopathol. Pharmacol. 2014; 27:121-6.","DOI":"10.1177\/039463201402700116"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Correia O., Delgado L., Polonia J. Genital fixed drug eruption: cross-reactivity between doxycycline and minocycline. Clin. Exp. Dermatol. 1999; 24:137.","DOI":"10.1046\/j.1365-2230.1999.00436.x"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Childs-Kean L.M., Shaeer K.M., Gupta S.V. et al. Aminoglycoside allergic reactions. Pharmacy. 2019; 7:124.","DOI":"10.3390\/pharmacy7030124"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Schorr W.F., Ridgway H.B. Tobramycin-neomycin cross-sensitivity. Contact Dermat. 1977; 3: 133\u2013137.","DOI":"10.1111\/j.1600-0536.1977.tb03627.x"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Romano A., Caubet J.C. Antibiotic allergies in children and adults: From clinical symptoms to skin testing diagnosis. J. Allergy Clin. Immunol. Pract. 2014; 2: 3\u201312.","DOI":"10.1016\/j.jaip.2013.11.006"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Hung Y.P., Lee N.Y., Chang C.M. et al. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review. Clin. Ther. 2009; 31: 1977-86.","DOI":"10.1016\/j.clinthera.2009.09.010"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Hsiao S.H., Chou C.H., Lin W.L. et al. High risk of cross-reactivity between vancomycin and sequential teicoplanin therapy. J. Clin. Pharm. Ther. 2012; 37: 296-300.","DOI":"10.1111\/j.1365-2710.2011.01291.x"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"32. Khan D.A., Knowles S.R., Shear N.H. Sulfonamide hypersensitivity: fact and fiction. J. Allergy Clin. Immunol. Pract. 2019; 7: 2116-23.","DOI":"10.1016\/j.jaip.2019.05.034"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Strom B.L., Schinnar R., Apter A.J. et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N. Engl. J. Med. 2003; 349 (17): 1628-35.","DOI":"10.1056\/nejmoa022963"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Mishra D., Mobashir M., Zaheer M.S. Fixed drug eruption and cross-reactivity between tinidazole and metronidazole. Int. J. Dermatol. 1990; 29: 740.","DOI":"10.1111\/j.1365-4362.1990.tb03788.x"},{"key":"ref34","unstructured":"35. Thami G.P., Kanwar A.J. Fixed drug eruption due to metronidazole and tinidazole without cross-sensitivity to secnidazole. Dermatology. 1998; 196: 368."}],"container-title":["Wiadomo\u015bci Lekarskie"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T13:14:05Z","timestamp":1660396445000},"score":1,"resource":{"primary":{"URL":"https:\/\/wiadlek.pl\/wp-content\/uploads\/archive\/2022\/06\/WLek202207126.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022]]},"published-print":{"date-parts":[[2022,7]]}},"URL":"https:\/\/doi.org\/10.36740\/wlek202207126","archive":["Internet Archive"],"relation":{},"ISSN":["0043-5147"],"issn-type":[{"value":"0043-5147","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}